Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in VIR — Vir Biotechnology, Inc.

CIK 1179392 NEW YORK, NY
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,313,213
-$1,584,653 QoQ
Shares Held
1,110,227
-22.9% QoQ
Ownership
0.656%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 237 holders
Holding Since
Jun 2021
16 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. VIR ranks #82 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,875,937 $564,713,315
2 MRNA
Moderna, Inc.
 7,193,530 $503,762,905
3 IONS
Ionis Pharmaceuticals Inc
 6,252,342 $495,748,197
4 REGN
Regeneron Pharmaceuticals, Inc.
 656,124 $409,119,558
5 BBIO
BridgeBio Pharma, Inc.
 4,722,185 $351,708,338
6 EXEL
Exelixis, Inc.
 4,209,861 $229,058,537
7 INCY
Incyte Corp
 2,003,559 $227,123,448
8 ARGX
Argenx SE
 185,638 $172,229,367

All Filings in VIR

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,313,213 1,110,227
2026-03-31 $12,897,866 1,439,494
2025-12-31 $3,555,052 589,561
2025-09-30 $3,707,503 649,300
2025-06-30 $1,862,859 369,615
2025-03-31 $1,766,026 272,535
2024-12-31 $1,804,729 245,876
2024-09-30 $2,067,419 276,024
2024-06-30 $3,173,250 356,545
2024-03-31 $663,636 65,512
2023-12-31 $588,630 58,512
2023-09-30 $202,392 21,600
2023-06-30 $1,381,063 56,301
2023-03-31 $953,767 40,987
2022-12-31 $473,297 18,700
2021-06-30 $1,243,464 26,300